William Fissell, M.D.
| Appointed: |
2007 |
| Gender: |
Male |
| Languages: |
English |
Nephrology and Hypertension
Biomedical Engineering
Biographical Sketch
William Fissell, MD, has degrees in physics and electrical engineering from M.I.T., and he went on to apply his engineering training to treatment of patients with kidney disease first at Case Western Reserve University, University Hospitals of Cleveland, and the Louis B. Stokes Cleveland VA, where he completed medical school and residency.
Dr. Fissell moved to University of Michigan, Ann Arbor, for his fellowship in nephrology, where he trained with H. David Humes, pioneer of the first bioartificial kidney in clinical trials. He stayed at University of Michigan for his first two faculty appointments before moving to the Cleveland Clinic in 2007.
He has pioneered the application of silicon nanotechnology to hemodialysis and hemofiltration, and presently directs the Renal Nanotechnology Laboratory and the Innovations Center for Extracorporeal Therapy at Cleveland Clinic.
Dr. Fissell's clinical practice focuses on the care of critically ill patients with renal disease.
Education & Fellowships
| Medical School: | Case Western Reserve University School of Medicine, Cleveland, OH |
|
| Internship: | University Hospitals of Cleveland, Medicine, Cleveland, OH |
| Residency: | University Hospitals of Cleveland, Medicine, Cleveland, OH |
| Fellowship: | University of Michigan Health System, Nephrology, Ann Arbor, MI |
| Other Education: | (Undergraduate) Massachusetts Institute of Technology, Cambridge, MA |
Certifications
Nephrology
Internal Medicine
Specialty Interests
Critical care nephrology, dialysis and hemofiltration membrane technology, novel therapies in treatment of ESRD, Dialysis, hemofiltration membrane technology.
Innovations & Patents
Dr. Fissell is among the inventors of a pioneering new membrane technology, patented in 2005. These membranes allow miniaturization of dialysis devices, and, someday, implantable dialysis devices.
Professional Memberships
- American Society of Nephrology
- ASAIO
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 8/4/2008, Dr. Fissell has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Fissell receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
